KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Goodwill & Intangibles (2016 - 2025)

Travere Therapeutics' Goodwill & Intangibles history spans 13 years, with the latest figure at $113.9 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 8.68% year-over-year to $113.9 million; the TTM value through Dec 2025 reached $113.9 million, up 8.68%, while the annual FY2025 figure was $113.9 million, 8.68% up from the prior year.
  • Goodwill & Intangibles reached $113.9 million in Q4 2025 per TVTX's latest filing, up from $110.2 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $163.8 million in Q1 2023 to a low of $97.9 million in Q4 2022.
  • Average Goodwill & Intangibles over 5 years is $127.0 million, with a median of $112.1 million recorded in 2025.
  • Peak YoY movement for Goodwill & Intangibles: tumbled 37.73% in 2024, then rose 8.68% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $149.3 million in 2021, then tumbled by 34.46% to $97.9 million in 2022, then grew by 7.53% to $105.2 million in 2023, then fell by 0.45% to $104.8 million in 2024, then increased by 8.68% to $113.9 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Goodwill & Intangibles are $113.9 million (Q4 2025), $110.2 million (Q3 2025), and $106.4 million (Q2 2025).